Thoughts on signal detection in pharmacovigilance.

Suppr

超能文献

作者信息

Shakir Saad A W

机构信息

Drug Safety Research Unit, Southampton, UK.

出版信息

Drug Saf. 2007;30(7):603-6. doi: 10.2165/00002018-200730070-00005.

DOI:10.2165/00002018-200730070-00005

PMID:17604411

Abstract

摘要

相似文献

Thoughts on signal detection in pharmacovigilance.

Drug Saf. 2007;30(7):603-6. doi: 10.2165/00002018-200730070-00005.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Principles of signal detection in pharmacovigilance.

Drug Saf. 1997 Jun;16(6):355-65. doi: 10.2165/00002018-199716060-00002.

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Updating the French method for the causality assessment of adverse drug reactions.

Therapie. 2013 Mar-Apr;68(2):69-76. doi: 10.2515/therapie/2013016. Epub 2013 Jun 18.

[The French pharmacovigilance system: structure and missions].

Presse Med. 2000 Jan 22;29(2):102-6.

Innovations for the future of pharmacovigilance.

Drug Saf. 2007;30(7):631-3. doi: 10.2165/00002018-200730070-00013.

Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in Pharmacovigilance.

Curr Drug Saf. 2020;15(2):124-130. doi: 10.2174/1574886315666200224101011.

Signal detection: historical background.

Drug Saf. 2007;30(7):607-9. doi: 10.2165/00002018-200730070-00006.

引用本文的文献

Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?

Eur J Clin Pharmacol. 2008 Aug;64(8):829-34. doi: 10.1007/s00228-008-0497-3. Epub 2008 May 29.

本文引用的文献

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

Drug Saf. 2006;29(2):175-81. doi: 10.2165/00002018-200629020-00008.

The discovery of drug-induced illness.

N Engl J Med. 1977 Mar 3;296(9):481-5. doi: 10.1056/NEJM197703032960904.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Thoughts on signal detection in pharmacovigilance.

Drug Saf. 2007;30(7):603-6. doi: 10.2165/00002018-200730070-00005.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Principles of signal detection in pharmacovigilance.

Drug Saf. 1997 Jun;16(6):355-65. doi: 10.2165/00002018-199716060-00002.

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Updating the French method for the causality assessment of adverse drug reactions.

Therapie. 2013 Mar-Apr;68(2):69-76. doi: 10.2515/therapie/2013016. Epub 2013 Jun 18.

[The French pharmacovigilance system: structure and missions].

Presse Med. 2000 Jan 22;29(2):102-6.

Innovations for the future of pharmacovigilance.

Drug Saf. 2007;30(7):631-3. doi: 10.2165/00002018-200730070-00013.

Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in Pharmacovigilance.

Curr Drug Saf. 2020;15(2):124-130. doi: 10.2174/1574886315666200224101011.

Signal detection: historical background.

Drug Saf. 2007;30(7):607-9. doi: 10.2165/00002018-200730070-00006.

引用本文的文献

Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?

Eur J Clin Pharmacol. 2008 Aug;64(8):829-34. doi: 10.1007/s00228-008-0497-3. Epub 2008 May 29.

本文引用的文献

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

Drug Saf. 2006;29(2):175-81. doi: 10.2165/00002018-200629020-00008.

The discovery of drug-induced illness.

N Engl J Med. 1977 Mar 3;296(9):481-5. doi: 10.1056/NEJM197703032960904.